XERS Xeris Biopharma Holdings, Inc.
P/E
--
Forward P/E
22.17
Price/Sales
5.54
Beta
0.838
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Xeris Biopharma's third quarter 2026 revenue of $107M beat estimates by 77% as Recorlev sales surged
Xeris Biopharma reported third quarter 2026 financial results that significantly exceeded consensus expectations, driven by a 93% year-over-year increase in...
Xeris Pharmaceuticals Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Analysts expect Xeris Pharmaceuticals to report Q3 2026 revenue of $60.5 million and EPS of $0.02, while the current stock price of $3.55 remains significantly...